Virtual ENDO 2020 News Conferences to Highlight Advances in Technology, Thyroid Health, More

Researchers will discuss how artificial intelligence and drones are being incorporated into health care when they share the latest emerging science during the Endocrine Society’s ENDO 2020 virtual news conferences March 30-31.

The press conferences will feature select abstracts that were slated to be presented at ENDO 2020, the Endocrine Society’s annual meeting. The event was cancelled amid concerns about COVID-19. The abstracts will be published in a supplemental issue of the Journal of the Endocrine Society, while features based on these news conferences will be featured in upcoming issues of Endocrine News

To register to view the news conferences, email [email protected].

News Conference Schedule:

Monday, March 30

Emerging technologies, part I (10 a.m. EDT): Experts will explore how drones and non-drug therapies targeting the microbiome are being used in the endocrinology field.

Diabetes (11:30 a.m. EDT): Researchers will discuss patient data from the first hybrid closed-loop system approved by the U.S. Food and Drug Administration, the impact diabetes has on bariatric surgery outcomes, blood sugar management and cognitive function following a stroke, and how tear glands can signal poor blood glucose control.

Endocrine-disrupting chemicals (2 p.m. EDT): Researchers will share how bisphenol A and related chemicals impact blood pressure and the ways PFAS exposure affects future generations’ risk of obesity.

Emerging technologies, part II (5 p.m. EDT): Experts will discuss how artificial intelligence is being used to improve osteoporosis treatment.

Tuesday, March 31

Obesity (10 a.m. EDT): Researchers will explain how the amount of attention we unconsciously pay to food impacts the effectiveness of bariatric surgery, how baseline fitness affects our ability to lose weight and how cooking with coconut oil may lower the risk of diabetes and cardiovascular disease.

Thyroid health (Noon EDT): Studies will highlight the first medication approved for the treatment of thyroid eye disease, how emerging cancer therapies are affecting thyroid health, and ways to convey a positive prognosis to individuals with thyroid cancer.

To register to attend the news conferences, email [email protected]. Credentialed journalists will be given priority to attend. Recordings will be available on the Society’s website following the event.

# # #

You may also like

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

  • New Position Statement Focuses on Patient Experience in Diabetes Care

    Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &…

Find more in